These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A roadmap for the synthesis of separation networks for the recovery of bio-based chemicals: Matching biological and process feasibility. Yenkie KM; Wu W; Clark RL; Pfleger BF; Root TW; Maravelias CT Biotechnol Adv; 2016 Dec; 34(8):1362-1383. PubMed ID: 27756578 [TBL] [Abstract][Full Text] [Related]
23. Interaction of cell culture with downstream purification: a case study. Berthold W; Kempken R Cytotechnology; 1994; 15(1-3):229-42. PubMed ID: 7765936 [TBL] [Abstract][Full Text] [Related]
24. Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives. Singh N; Arunkumar A; Chollangi S; Tan ZG; Borys M; Li ZJ Biotechnol Bioeng; 2016 Apr; 113(4):698-716. PubMed ID: 26302443 [TBL] [Abstract][Full Text] [Related]
25. Inactivation of proteins and other biological macromolecules during chromatographic methods of bioseparation. Sadana A Bioseparation; 1992; 3(2-3):145-65. PubMed ID: 1369239 [TBL] [Abstract][Full Text] [Related]
26. Protein inactivations during novel bioseparation techniques. Sadana A Bioseparation; 1994 Feb; 4(1):39-61. PubMed ID: 7764586 [TBL] [Abstract][Full Text] [Related]
27. Methods in cell separation for biomedical application: cryogels as a new tool. Kumar A; Bhardwaj A Biomed Mater; 2008 Sep; 3(3):034008. PubMed ID: 18708708 [TBL] [Abstract][Full Text] [Related]
28. Continuous downstream processing of biopharmaceuticals. Jungbauer A Trends Biotechnol; 2013 Aug; 31(8):479-92. PubMed ID: 23849674 [TBL] [Abstract][Full Text] [Related]
29. Large-scale extraction of proteins. Cunha T; Aires-Barros R Mol Biotechnol; 2002 Jan; 20(1):29-40. PubMed ID: 11876297 [TBL] [Abstract][Full Text] [Related]
30. Hydrothermal liquefaction of organic resources in biotechnology: how does it work and what can be achieved? Sandquist J; Tschentscher R; Del Alamo Serrano G Appl Microbiol Biotechnol; 2019 Jan; 103(2):673-684. PubMed ID: 30474725 [TBL] [Abstract][Full Text] [Related]
31. Bioseparation in antibody manufacturing: the good, the bad and the ugly. Gottschalk U Biotechnol Prog; 2008; 24(3):496-503. PubMed ID: 18442255 [TBL] [Abstract][Full Text] [Related]
33. Mass spectrometry to describe product and contaminant adsorption properties for bioprocess development. Berrill A; Ho SV; Bracewell DG Biotechnol Bioeng; 2011 Aug; 108(8):1862-71. PubMed ID: 21351073 [TBL] [Abstract][Full Text] [Related]
34. Chromatography in the downstream processing of biotechnological products. Freitag R; Horváth C Adv Biochem Eng Biotechnol; 1996; 53():17-59. PubMed ID: 8578972 [TBL] [Abstract][Full Text] [Related]
35. Reverse micellar extraction for downstream processing of proteins/enzymes. Krishna SH; Srinivas ND; Raghavarao KS; Karanth NG Adv Biochem Eng Biotechnol; 2002; 75():119-83. PubMed ID: 11787493 [TBL] [Abstract][Full Text] [Related]
36. Downstream process development in biotechnological itaconic acid manufacturing. Magalhães AI; de Carvalho JC; Medina JDC; Soccol CR Appl Microbiol Biotechnol; 2017 Jan; 101(1):1-12. PubMed ID: 27847989 [TBL] [Abstract][Full Text] [Related]
37. Magnetic Separation in Bioprocessing Beyond the Analytical Scale: From Biotechnology to the Food Industry. Schwaminger SP; Fraga-García P; Eigenfeld M; Becker TM; Berensmeier S Front Bioeng Biotechnol; 2019; 7():233. PubMed ID: 31612129 [TBL] [Abstract][Full Text] [Related]
38. A review on current downstream bio-processing technology of vaccine products. Li M; Qiu YX Vaccine; 2013 Feb; 31(9):1264-7. PubMed ID: 23313813 [TBL] [Abstract][Full Text] [Related]